Our goal
With our knowledge and products we help people to heal, alleviate and recover from their illness.
Contact us
JBfreelife
JBfreelife distributes innovative products and supplies in the field of healthcare (life science/ medical technology).
Die Vision
JBfreelife's mission is to provide you with medical or biomedical products, advice and support in accordance with our mission "Together for a healthy life". Our products support you in the diagnosis, treatment and cure as well as prevention of diseases.
Introduction JBfreelife
JBfreelife is a division of JBM&IC GmbH. JBM&IC offers business development support services for start-ups as well as national and international companies.
Learn more about
Disease - Virus
Coronavirus and Covid 19
Corona viruses are enveloped RNA viruses that are widely distributed among humans, other mammals and birds and cause respiratory diseases, enteric diseases, liver diseases and neurological disorders. It is known that seven types of corona virus cause disease in humans. Four virus-229E. OC43. NL63 and HKu1- are widespread and typically cause cold symptoms in immunocompetent individuals.
Four of the three other strains - severe coronavirus with acute respiratory syndrome (SARS-Cov), coronavirus with respiratory syndrome in the Middle East (MERS-Cov) and novel coronavirus 2019 (COVID-) 19) - are of zoonotic (animal) origin and have been linked to sometimes fatal diseases. IgG and IgM antibodies against the novel Coronavirus 2019 can be detected 2-3 weeks after infection. lgG remains positive, but antibody levels decrease over time.
Questions and help
We take care of your questions
Phone
+49 7476 4490604
Our Address
Heidelbergstraße 16,
72406 Bisingen
Germany
Reachability by phone
Monday - Friday
9:00 am - 8:00 pm
Saturday - Sunday
closed
Contents and descriptions
The contents of the descriptions are taken from the following sources:
1. Weltgesundheitsorganisation (WHO). Erklärung der WHO zum Cluster von Lungenentzündungsfällen in Wuhan, China. Peking: WHO; 9. Januar 2020. [Abgerufen am 26. Januar 2020[. https:// www.who.intlchina/news/detail/09-01-2020-who- statement-regarding- cluster-of-pneumonia-cases-in-wuhan-china
2. Weiss SR, Leibowitz JL. Coronavirus-Pathogenese. Adv Virus Res 2011 ;81 :85-164.
PMID:22094080 - 001:10.1 016/B978-0-12-385885-6.00009-2
3. Su S, Wong G, Shi W, et al. Epidemiologie, genetische Rekombination und Pathogenese von Coronaviren. Trends Microbiol 2016;24:490-502.PMI0:27012512 DOI:l0.l016/j.tim.2016.03.003
4. Cui J, Li F, Shi ZL. Ursprung und Entwicklung pathogener Coronaviren.
Nat Rev Microbiol2019; 17:181-192. PM10:30531947 001:10.1038/s41579-018-0118-9
5. Weltgesundhe~sorganisation (WHO). Coronovirus. https:/Iwww.
who.intlhealth-topics/coronavirus